Advanced BioMedical Technologies Inc. (ABMT)
OTHER OTC:ABMT
Total Valuation
Advanced BioMedical Technologies has a market cap or net worth of $50.00K. The enterprise value is $6.86M.
Market Cap$50.00K
Enterprise Value$6.86M
Share Statistics
Advanced BioMedical Technologies has 100,000,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding100,000,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Advanced BioMedical Technologies’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 15.99%.
Return on Equity (ROE)0.06
Return on Assets (ROA)-1.30
Return on Invested Capital (ROIC)15.99%
Return on Capital Employed (ROCE)0.02
Revenue Per Employee15.94K
Profits Per Employee-30.32K
Employee Count17
Asset Turnover0.68
Inventory Turnover0.20
Valuation Ratios
The current PE Ratio of Advanced BioMedical Technologies is ―. Advanced BioMedical Technologies’s PEG ratio is 0.23.
PE Ratio―
PS Ratio13.03
PB Ratio-0.44
Price to Fair Value-0.44
Price to FCF-4.81
Price to Operating Cash Flow-0.05
PEG Ratio0.23
Income Statement
In the last 12 months, Advanced BioMedical Technologies had revenue of 270.99K and earned -515.49K in profits. Earnings per share was -0.01.
Revenue270.99K
Gross Profit221.88K
Operating Income-179.88K
Pretax Income-515.49K
Net Income-515.49K
EBITDA-166.01K
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was -626.35K and capital expenditures 272.00, giving a free cash flow of -626.08K billion.
Operating Cash Flow-626.35K
Free Cash Flow-626.08K
Free Cash Flow per Share>-0.01
Dividends & Yields
Advanced BioMedical Technologies pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.57
52-Week Price Change0.00%
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)100.00
Average Volume (3m)―
Important Dates
Advanced BioMedical Technologies upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Advanced BioMedical Technologies as a current ratio of 0.04, with Debt / Equity ratio of -85.82%
Current Ratio0.04
Quick Ratio<0.01
Debt to Market Cap1.93
Net Debt to EBITDA-41.00
Interest Coverage Ratio-0.54
Taxes
In the past 12 months, Advanced BioMedical Technologies has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Advanced BioMedical Technologies EV to EBITDA ratio is -62.27, with an EV/FCF ratio of -14.07.
EV to Sales38.14
EV to EBITDA-62.27
EV to Free Cash Flow-14.07
EV to Operating Cash Flow-14.07
Balance Sheet
Advanced BioMedical Technologies has $5.70K in cash and marketable securities with $7.09M in debt, giving a net cash position of -$7.09M billion.
Cash & Marketable Securities$5.70K
Total Debt$7.09M
Net Cash-$7.09M
Net Cash Per Share-$0.07
Tangible Book Value Per Share-$0.11
Margins
Gross margin is 81.88%, with operating margin of -66.38%, and net profit margin of -190.22%.
Gross Margin81.88%
Operating Margin-66.38%
Pretax Margin-190.22%
Net Profit Margin-190.22%
EBITDA Margin-61.26%
EBIT Margin-68.23%
Analyst Forecast
The average price target for Advanced BioMedical Technologies is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―